Accendra Health announced exchange offers to swap outstanding 4.500% 2029 Notes and 6.625% 2030 Notes for newly issued 9.000% First Lien Notes due 2032 and 9.750% Second Lien Notes due 2033, along with consent solicitations to amend existing note indentures. The company is also raising $326.25 million in new first lien notes, indicating a debt restructuring to extend maturities and modify covenant terms.